Industry News
- Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
- GSK announces results of first Phase III trial evaluating Tykerb ®/Tyverb® (lapatinib) plus Herceptin® (trastuzumab)
- ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)
- CDC Recommends ZOSTAVAX®, Merck's Shingles Vaccine, for All Appropriate Adults Aged 60 and Older
- Merck Wins Appeal in VIOXX® Case
- New studies show FlexPen® superiority to SoloStar® in dose accuracy (15 May 2008)
- As Part of New Transparency Initiative Pfizer Releases List of Grants and Charitable Contributions Made in the First Quarter of 2008
- Wyeth's Pristiq, a New Treatment for Major Depressive Disorder
- XIENCE™ V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
- FDA Approves AstraZeneca’s Seroquel for Maintenance Treatment in Bipolar Disorder
- Covidien Announces Acquisition of Specialty Injection Devices from Pinyons Medical Technology, Inc.
- New study shows lowering co-payments can lead to lower total healthcare costs, improved overall health
- GlaxoSmithKline named a top employer for promoting healthy lifestyles
- Cervarix™ provides longest duration of sustained neutralising antibodies reported for any vaccine against HPV 16 and 18 to date
- Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
- Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
- Mylan Launches Paroxetine Hydrochloride Extended-Release Tablets
- Pfizer Extends 10 Million Yuan to Earthquake Victims and Relief Efforts in China
- MIRCERA keeps haemoglobin levels stable with significantly fewer dose changes than with other ESAs
- In a Phase II study, Novartis Meningitis B vaccine has potential to produce a protective immune response in infants[1], the age group most at risk
- Health Care Providers Sue State of California Over Cuts in Medi-Cal Payments
- Abbott Scientists Present A New Approach for Treating Attention-Deficit Hyperactivity Disorder
- New Abbott Study of Investigational Vicodin CR™ Meets Primary Efficacy Endpoints in Phase III Trial
- AstraZeneca Submits sNDA for Seroquel XR™ for the Treatment of Generalised Anxiety Disorder – a First for the Atypical Antipsychotic Class of Medicines
- FDA Approves Covidien Contrast Delivery System with RFID
- Preliminary Results from Phase 2 Genzyme Study
- Children, Teens at Greater Risk Than Adults of Exposure to Damaging UV
- ONETOUCH® LAUGH & LEARN SWEEPSTAKES TO AWARD SCHOLARSHIPS FOR SUMMER CAMP
- OROS® Methylphenidate in Adults with ADHD: New Insights
- Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis
- Solvay Pharmaceuticals Associate Director Honored as Industry Rising Star by Healthcare Businesswomen’s Association
- Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
- The FluSTAR Custom Retail Report - National 11-06-07
- In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
- Lilly Receives NCQA Design Certification for Depression Care Management Program
- Lilly Contributes $10.8 Million to United Way Annual Campaign
- Fabre Kramer Pharmaceuticals receives decision from FDA on gepirone ER for major depressive disorder
- GlaxoSmithKline initiates trials of Promacta®/Revolade™ (eltrombopag) to investigate the potential to aid hepatitis C patients in achieving sustained virological response
Product Archive
Search our archive of all past Industry News, Product Alerts, and Product Backorders by date, keyword, brand, or generic name.
Today's Product News
Click here for more news.
